This registry is created under the sponsorship of the Outpatient Endovascular and Interventional Society (OEIS) to monitor the clinical course and treatment outcomes of patients undergoing office-based endovascular procedures.
Study Type
OBSERVATIONAL
Enrollment
600,000
Outpatient Endovascular Interventional Society (OEIS)
Hoffman Estates, Illinois, United States
RECRUITINGAntiplatelet Therapy (ACC/AHA/PAD Coalition)
To collect the clinical variables of Patients undergoing endovascular procedures in an outpatient angiograPercentage of patients with PAD that have been prescribed an antiplatelet medication at the reported encounter.
Time frame: 30 days
Preventive Care and Screening: Tobacco Use
Screening and Cessation Intervention. Percentage of patients aged 18 years and older who were screened for tobacco use one or more times within 24 months AND who received cessation counseling intervention if identified as a tobacco user.
Time frame: 30 days
Lipid-Lowering Medications for Patients with PAD
The rate at which patients with documented peripheral artery disease have documentation of a currently prescribed antihyperlipidemic medication treatment. This may include one of the following: Statin, Bile acid sequestrants, Niacin, Ezetemibe, Fibrates, PCSK9 Inhibitors
Time frame: 30 days
Optimal vascular care
This measure is a composite score of appropriate vascular care measures for treatment of PAD. This measure is a composite result of 1: Antiplatelet Therapy; 2: Preventive Care and Screening: Tobacco Use; and 3: Lipid-Lowering Medications (Statin) for Patients with PAD
Time frame: 30 days
Preventive Care and Screening: Influenza Immunization.
Time frame: 30 days
Pneumonia Vaccination Status for Older Adults.
Time frame: 30 days
Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented.
Time frame: 30 days
Appropriate non-invasive arterial testing for patients with intermittent claudication who are undergoing a lower extremity peripheral vascular intervention.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Proportion of patients with non-invasive evaluations present/available prior to lower extremity peripheral vascular interventions in patients with intermittent claudication.
Time frame: 30 days
Appropriate non-invasive arterial testing for patients with critical limb ischemia who are undergoing a LE peripheral vascular intervention.
Proportion of patients with non-invasive evaluations present/available prior to LE peripheral vascular interventions in patients with critical limb ischemia.
Time frame: 30 days
Emergent transfer from an outpatient, ambulatory surgical center, or office setting.
Rate of emergent transfer from an outpatient, ASC, or office setting to an acute care facility as a result of an invasive peripheral vascular intervention.
Time frame: 30 days